Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 12-Aug-20 9:04 PM View:  | Checkmate Pharmaceuticals, ... (CMPI) | 11-Aug-20 | Conversion Duplicate | 3,473,370 | -- | -- | 100% 0 to 3.47M | |
| 12-Aug-20 9:04 PM View: | Checkmate Pharmaceuticals, ... (CMPI) | 11-Aug-20 | Purchase | 133,333 | $15.00 | $2,000,000.00 | 4% 3.47M to 3.61M | |
| 30-Jan-18 4:30 PM View: | Synlogic, Inc. (SYBX) | 26-Jan-18 | Grant | 150,000 | $9.75 | $1,462,500.00 | 35% 424.97K to 574.97K | (77%) |
| 30-Dec-16 6:51 PM View: | Tranzyme, Inc. (OCRX) | 31-Oct-16 | Acquisition (other) | 14,328 | -- | -- | 2% 848.22K to 862.55K | |
| 30-Dec-16 6:51 PM View: | Tranzyme, Inc. (OCRX) | 31-Oct-16 | Disposition (other) | 848,222 | -- | -- | (98%) 862.55K to 14.33K | |
| 30-Dec-16 6:51 PM View: | Tranzyme, Inc. (OCRX) | 12-Sep-16 | Market Sale | 6,512 | $2.29 | $14,925.50 | (< 1%) 854.73K to 848.22K | 22% |
| 30-Dec-16 6:51 PM View: | Tranzyme, Inc. (OCRX) | 12-Sep-16 | Exercise (in-the money or at-the-money) | 22,264 | $0.67 | $14,916.90 | 3% 832.47K to 854.73K | |
| 10-Feb-17 10:00 PM View: | Tranzyme, Inc. (OCRX) | 29-Jul-16 | Market Sale | 11,969 | $2.53 | $30,281.60 | (100%) 11.97K to 0 | 29% |
| 13-Jul-16 8:32 PM View: | Tranzyme, Inc. (OCRX) | 11-Jul-16 | Option Exercise | 11,969 | $1.26 | $15,080.90 | 100% 0 to 11.97K | |
| 06-Oct-15 1:36 PM View: | Synlogic, Inc. (SYBX) | 06-Oct-15 | Acquisition (other) Duplicate | 289,841 | -- | -- | 8% 3.66M to 3.95M | |
| 06-Oct-15 1:36 PM View: | Synlogic, Inc. (SYBX) | 06-Oct-15 | Purchase Duplicate | 857,142 | $7.00 | $5,999,990.00 | 22% 3.95M to 4.8M | |
| 06-Oct-15 1:36 PM View: | Synlogic, Inc. (SYBX) | 05-Oct-15 | Conversion Duplicate | 1,827,830 | -- | -- | 100% 1.83M to 3.66M | |
| 20-Mar-14 6:22 PM View: | Tranzyme, Inc. (OCRX) | 18-Mar-14 | Disposition (other) Duplicate | 410,022 | -- | -- | (33%) 1.24M to 832.47K | |
| 17-Jul-13 5:49 PM View: | Tranzyme, Inc. (OCRX) | 15-Jul-13 | Acquisition (other) | 851,326 | -- | -- | 100% 0 to 851.33K | |
| 17-Jul-13 5:49 PM View: | Tranzyme, Inc. (OCRX) | 15-Jul-13 | Purchase Duplicate | 391,166 | $6.03 | $2,357,320.00 | 46% 851.32K to 1.24M | |
| 27-Mar-12 7:50 PM View: | Trius Therapeutics Inc (TSRX) | 26-Mar-12 | Option Exercise | 9,302 | $1.29 | $11,999.60 | 100% 0 to 9.3K | |
| 20-Jan-12 9:30 PM View: | Trius Therapeutics Inc (TSRX) | 19-Jan-12 | Market Sale (Planned) | 2,600 | $5.64 | $14,661.90 | (2%) 115.73K to 113.13K | (142%) |
| 20-Jan-12 9:30 PM View: | Trius Therapeutics Inc (TSRX) | 18-Jan-12 | Market Sale (Planned) | 4,300 | $5.56 | $23,894.70 | (4%) 120.03K to 115.73K | (146%) |
| 17-Jan-12 6:33 PM View: | Trius Therapeutics Inc (TSRX) | 17-Jan-12 | Market Sale (Planned) | 16,100 | $5.43 | $87,426.20 | (12%) 136.13K to 120.03K | (152%) |
| 17-Jan-12 6:33 PM View: | Trius Therapeutics Inc (TSRX) | 13-Jan-12 | Market Sale (Planned) | 8,522 | $5.46 | $46,568.50 | (6%) 144.65K to 136.13K | (150%) |
| 17-Jan-12 6:32 PM View: | Trius Therapeutics Inc (TSRX) | 12-Jan-12 | Acquisition (other) Duplicate | 144,622 | -- | -- | 4% 3.62M to 3.76M | |
| 17-Jan-12 6:32 PM View: | Trius Therapeutics Inc (TSRX) | 12-Jan-12 | Disposition (other) Duplicate | 3,615,570 | -- | -- | (96%) 3.76M to 144.65K | |
| 23-Dec-10 6:18 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 23-Dec-10 | Market Sale | 198,940 | $8.09 | $1,609,500.00 | (100%) 198.94K to 1 | 96% |
| 23-Dec-10 6:18 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 22-Dec-10 | Market Sale | 250,721 | $8.30 | $2,081,660.00 | (56%) 449.66K to 198.94K | 96% |
| 23-Dec-10 6:18 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 21-Dec-10 | Market Sale | 375,339 | $8.38 | $3,145,120.00 | (45%) 825.0K to 449.66K | 96% |
| 21-Dec-10 5:34 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 20-Dec-10 | Market Sale | 325,000 | $8.50 | $2,763,990.00 | (28%) 1.15M to 825.0K | 96% |
| 21-Dec-10 5:34 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 17-Dec-10 | Market Sale | 131,254 | $8.76 | $1,149,580.00 | (10%) 1.28M to 1.15M | 96% |
| 10-Aug-10 1:55 PM View: | Trius Therapeutics Inc (TSRX) | 06-Aug-10 | Conversion Duplicate | 2,785,570 | $1.40 | $3,913,070.00 | 60% 4.68M to 7.46M | |
| 10-Aug-10 1:55 PM View: | Trius Therapeutics Inc (TSRX) | 06-Aug-10 | Purchase Duplicate | 830,000 | $5.00 | $4,150,000.00 | 11% 7.46M to 8.29M | |
| 19-Mar-10 7:00 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 19-Mar-10 | Market Sale | 210,000 | $6.00 | $1,260,040.00 | (14%) 1.49M to 1.28M | 95% |
| 19-Mar-10 7:00 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 18-Mar-10 | Market Sale | 338,000 | $6.15 | $2,077,690.00 | (18%) 1.83M to 1.49M | 95% |
| 19-Mar-10 7:00 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 17-Mar-10 | Market Sale | 152,000 | $6.29 | $955,472.00 | (8%) 1.98M to 1.83M | 95% |
| 11-Sep-09 6:26 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 10-Sep-09 | Market Sale | 400,000 | $9.18 | $3,670,000.00 | (17%) 2.38M to 1.98M | 96% |
| 13-Aug-09 8:20 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 12-Aug-09 | Market Sale | 400,000 | $8.00 | $3,200,000.00 | (14%) 2.78M to 2.38M | 96% |
| 02-Sep-08 7:24 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 29-Aug-08 | Market Sale | 700 | $12.09 | $8,460.20 | (< 1%) 2.78M to 2.78M | 98% |
| 29-Aug-08 3:59 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 28-Aug-08 | Market Sale | 10,800 | $12.05 | $130,091.00 | (< 1%) 2.79M to 2.78M | 98% |
| 29-Aug-08 3:59 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 27-Aug-08 | Market Sale | 20,000 | $12.05 | $241,040.00 | (< 1%) 2.81M to 2.79M | 98% |
| 25-Aug-08 9:10 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 25-Aug-08 | Market Sale | 4,800 | $12.00 | $57,612.00 | (< 1%) 2.82M to 2.81M | 98% |
| 25-Aug-08 9:10 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 21-Aug-08 | Market Sale | 5,300 | $12.00 | $63,600.00 | (< 1%) 2.82M to 2.82M | 98% |
| 18-Dec-07 1:46 PM View: | Anesiva, Inc. (ANSV.PK) | 18-Dec-07 | Market Purchase | 3,703,700 | $4.05 | $15,000,000.00 | 308% 1.2M to 4.91M | (98%) |
| 03-May-07 1:22 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 01-May-07 | Conversion Duplicate | 2,822,850 | -- | -- | 100% 0 to 2.82M | |
| 16-Aug-06 2:19 PM View: | Anesiva, Inc. (ANSV.PK) | 15-Aug-06 | Market Purchase | 1 | $6.86 | $6.86 | < 1% 1.2M to 1.2M | (99%) |
| 20-Mar-06 9:20 PM View: | Threshold Pharmaceuticals I... (MTEM) | 16-Mar-06 | Market Sale | 2,562,000 | $14.25 | $36,508,500.00 | (74%) 3.44M to 878.2K | 99% |
| 19-Dec-05 5:20 PM View: | Anesiva, Inc. (ANSV.PK) | 15-Dec-05 | Grant | 1,176,840 | -- | -- | 4453% 26.43K to 1.2M | |
| 09-Mar-05 2:24 PM View: | Threshold Pharmaceuticals I... (MTEM) | 08-Mar-05 | Market Purchase | 1 | $6.27 | $6.27 | < 1% 3.44M to 3.44M | (97%) |
| 10-Feb-05 5:48 PM View: | Threshold Pharmaceuticals I... (MTEM) | 09-Feb-05 | Conversion | 3,206,200 | -- | -- | (100%) (-3.21M) to 0 | |
| 10-Feb-05 5:48 PM View: | Threshold Pharmaceuticals I... (MTEM) | 09-Feb-05 | Market Purchase | 233,998 | $7.00 | $1,637,990.00 | 100% 0 to 234.0K | (98%) |
| 16-Dec-04 6:40 PM View: | Seattle Genetics Inc. (SGEN) | 16-Dec-04 | Market Sale | 6,500 | $7.00 | $45,500.00 | (< 1%) 692.39K to 685.89K | (899%) |
| 16-Dec-04 6:40 PM View: | Seattle Genetics Inc. (SGEN) | 15-Dec-04 | Market Sale | 10,000 | $7.00 | $70,000.00 | (1%) 702.39K to 692.39K | (899%) |
| 16-Dec-04 6:40 PM View: | Seattle Genetics Inc. (SGEN) | 14-Dec-04 | Market Sale | 40,000 | $7.00 | $280,000.00 | (5%) 742.39K to 702.39K | (899%) |